Denmark’s Novo Nordisk saw its shares fall 4.8% to 291.20 kroner by early afternoon, after it posted financials results for ...

Pharmaceutical regulation is undergoing its biggest shake-up in decades. On both sides of the Atlantic, policymakers are ...

Further evidence that US Department of Health and Human Services (HHS) secretary Robert F Kennedy Junior (RFK Jr) is willing ...

The US Food and Drug Administration (FDA) has approved an expanded indication of the intravenous (IV) formulation of South ...

Danish diabetes and obesity giant Novo Nordisk has announced the filing of 14 new lawsuits to safeguard patients from unsafe ...

Germany’s Bayer experienced a nightmare day’s trading Wednesday, with shares in the life sciences company more than 8% lower ...

US specialty pharma business SERB Pharmaceuticals is acquiring Y-mAbs Therapeutics (Nasdaq: YMAB) in a $412 million all-cash ...

Biologics-focused contract manufacturing and research organization Abenza announced that Geoffrey Glass has been appointed ...

Intas Pharmaceuticals has introduced Hetronifly (serplulimab) in the Indian market. The therapy is the first PD-1 inhibitor ...

Japanese drugmaker Nxera Pharma has unveiled a slate of new programs targeting obesity and related metabolic diseases, ...

Teva Pharmaceutical has received a green light from the US regulator for its biologic Ajovy (fremanezumab) to be used for ...

The UK’s National Institute for Health and Care Excellence (NICE) on August 6 recommended the use of US pharma giant Merck & ...